Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 August 2007, Vol. 110, No. 4, pp. 1178-1183.
Prepublished online as a Blood First Edition Paper on April 17, 2007; DOI 10.1182/blood-2007-01-066043.


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Appendix and Tables
Right arrow All Versions of this Article:
blood-2007-01-066043v1
110/4/1178    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Galli, M.
Right arrow Articles by Barbui, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Galli, M.
Right arrow Articles by Barbui, T.
Related Collections
Right arrow Hemostasis, Thrombosis, and Vascular Biology
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY

Clinical significance of different antiphospholipid antibodies in the WAPS (warfarin in the antiphospholipid syndrome) study

Monica Galli1, Giovanna Borrelli2, Eva Marie Jacobsen3, Rosa Maria Marfisi2, Guido Finazzi1, Roberto Marchioli2, Finn Wisloff3, Stefana Marziali1, Olivier Morboeuf4, and Tiziano Barbui1

1 Divisione di Ematologia, Ospedali Riuniti, Bergamo, Italy; 2 Laboratory of Epidemiology, Istituto Mario Negri Sud, S. Maria Imbaro, Chieti, Italy; 3 Ulleval Hospital, Oslo, Norway; 4 Diagnostica Stago, Asnieres, France

To assess the clinical significance of lupus anticoagulants (LAs) and antiphospholipid antibodies (aPLs) toward thrombosis and abortions, we measured them in 112 patients whose samples were available at enrollment in the warfarin in the antiphospholipid syndrome (WAPS) study. Enzyme-linked immunosorbent assay (ELISA) and coagulation test values in the highest and lowest tertiles were compared. When considered separately, IgG antibodies to ß2-glycoprotein I (aß2GPI) and prothrombin (aPT) were associated with anamnestic arterial and venous thrombosis, respectively, and those to annexin AV (aAnAV) with abortions. IgM antibodies to protein S and the lupus ratio of the dilute prothrombin time were associated with prospective thrombosis. No other association for IgM antibodies was seen. LA-positive patients who carried aß2GPI antibodies were at risk of anamnestic arterial and total thrombosis and aPT antibodies to that of anamnestic venous and total thrombosis. LA-positive patients who carried IgG aß2GPI and aAnAV antibodies were at risk for both anamnestic abortion and prospective thrombosis. Overall, these data support the inclusion of aß2GPI antibodies in and suggest the removal of anticardiolipin antibodies from the laboratory criteria of the antiphospholipid syndrome. They also suggest that the measurement of aPT and aAnAV antibodies is useful in some selected situations and that there is little role for IgM antibody detection.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
haematolHome page
M. Borrell, I. Tirado, J. Mateo, A. Oliver, A. Santamaria, and J. Fontcuberta
IgM anti-protein S antibodies as a risk factor for venous thrombosis
Haematologica, July 1, 2008; 93(7): 1115 - 1117.
[Full Text] [PDF]


Home page
haematolHome page
A. Membre, D. Wahl, V. Latger-Cannard, J.-P. Max, P. Lacolley, T. Lecompte, and V. Regnault
The effect of platelet activation on the hypercoagulability induced by murine monoclonal antiphospholipid antibodies
Haematologica, April 1, 2008; 93(4): 566 - 573.
[Abstract] [Full Text] [PDF]


Home page
JWatch Oncology and HematologyHome page
Diagnosing Antiphospholipid Antibody Syndrome
Journal Watch Oncology and Hematology, September 11, 2007; 2007(911): 1 - 1.
[Full Text]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2007 by American Society of Hematology         Online ISSN: 1528-0020